Resiniferatoxin

Generic Name: Resiniferatoxin

Brand Names: -

Drug Type: Small Molecule

Chemical Formula: C_₃₇H_₄₀O_₉

CAS Number: 57444-62-9

Unique Ingredient Identifier: A5O6P1UL4I

Background: Resiniferatoxin (RTX) is a naturally occurring, ultrapotent capsaicin analog that activates the vanilloid receptor in a subpopulation of primary afferent sensory neurons involved in nociception (the transmission of physiological pain).

Indication: Investigated for use/treatment in interstitial cystitis and urinary incontinence.

Associated Conditions: -

Associated Therapies: -

Clinical Trials

Resiniferatoxin for the Management of Refractory Morton s Neuroma Pain

Phase 1

Recruiting

Conditions: Morton's Neuroma

Interventions: Drug: Resiniferatoxin

First Posted Date: 2023-01-25

Last Posted Date: 2025-01-10

Lead Sponsor: National Institutes of Health Clinical Center (CC)

Target Recruit Count: 24

Registration Number: NCT05695339

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy